The association between fetal pyelectasis on second trimester ultrasound scan and aneuploidy among 25 586 low risk unselected women

Prenatal Diagnosis

Volumn 22, Issue 13, 2002, Pages 1201-1206

  Havuteu, A E ^a   Nikolopoulos, G ^a   Adinkra, P ^a   Lamont, R F ^a,b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b EALING HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Aneuploidy; Down's syndrome; Fetal pyelectasis; Ultrasound scan

Indexed keywords

ANEUPLOIDY; ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DEMOGRAPHY; ECHOGRAPHY; FEMALE; FETAL PYELECTASIS; FETUS; FETUS DISEASE; GENOTYPE; GESTATIONAL AGE; HUMAN; KARYOTYPING; KIDNEY PELVIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PHENOTYPE; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; ANEUPLOIDY; DILATATION, PATHOLOGIC; ENGLAND; FEMALE; FETAL DISEASES; HUMANS; KIDNEY PELVIS; MALE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES; SEX FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 0036933176     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.490     Document Type: Article

References (27)

1. Adra AM, Mejides AA, Dennaoui MS, Beydoun SN. 1995. Fetal pyelectasis: Is it always "physiologic"? Am J Obstet Gynecol 173: 1263-1266.
2. Benacerraf BR, Mandell J, Harlow BL, Frigoletto FD. 1990. Fetal pyelectasis and possible association with Down's syndrome. Obstet Gynecol 76: 58-60.
3. Benacerraf BR, Neuberg D, Bromley B, Frigoletto FD. 1992. Sonographic scoring index for prenatal detection of chromosomal abnormalities. J Ultrasound Med 11: 449-458.
4. Broadley P, McHugo J, Morgan I, Whittle MJ, Kilby MD. 1999. The 4 year outcome following the demonstration of bilateral renal pelvic dilatation on prenatal renal ultrasound. Br J Radiol 72: 265-270.
5. Congenital Malformation Register, North Thames (West), 2000. Report: Perinatal Public Health, Northwick Park Hospital; 14.
6. Corteville JE, Gray DL, Crane JP. 1991. Congenital hydronephrosis: Correlation of fetal ultrasonographic findings with infant outcome. Am J Obstet Gynecol 165: 384-388.
7. Corteville JE, Dicke JM, Crane JP. 1992. Fetal pyelectasis and Down syndrome: Is genetic amniocentesis warranted? Obstet Gynecol 79: 770-772.
8. Cuckle HS, Nancbabal K, Wald NJ. 1991. Birth prevalence of Down's syndrome in England and Wales. Prenat Diagn 11: 29-34.
9. Deren O, Mahoney MJ, Copel JA, Bahado-Singh RO. 1998. Subtle ultrasonographic anomalies: Do they improve the Down syndrome detection rate? Am J Obstet Gynecol 178: 441-445.
10. Dremesek PA, Gindl K, Voitl P, et al. 1997. Renal pyelectasis in fetuses and neonates: Diagnostic value of renal pelvis diameter in pre- and postnatal sonographic screening. AJR 168: 1017-1019.
11. Grignon A, Filion R, Filiatrault D, et al. 1986. Urinary tract dilatation in utero: Classification and clinical applications. Radiology 160: 645-647.
12. Guariglia L, Rosati P. 1998. Isolated mild fetal pyelectasis detected by transvaginal sonography in advanced maternal age. Obstet Gynecol 92: 833-836.
13. Howe DJ, Gornall R, Wellesley D, Boyle T, Barber J. 2000. Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scans. Br Med J 320: 606-610.
14. McCrory WW. 1972. Developmental Nephrology. Harvard University Press: Cambridge, Mass.; 51-79.
15. Nicolaides KH, Cheng HH, Abbas A, Snijders RJM, Gosden C. 1992. Fetal renal defects: Associated malformations and chromosomal defects. Fetal Diagn Ther 7: 1-11.
16. Nyberg DA, Luthy DA, Cheng EY, Sheley RC, Resta RG, Williams MA. 1995. Role of prenatal ultrasonograpy in women with positive screen for Down syndrome on the basis of maternal serum markers. Am J Obstet Gynecol 173: 1030-1035.
17. Seeds JW. 1997. Ultrasonographic screening for fetal aneuploidy. N Engl J Med 337: 1689-1690.
18. Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B. 1986. Randomised controlled trial of genetic amniocentesis in 4606 low risk women. Lancet 1: 1287-1293.
19. Verdin SM, Economides DL. 1998. The role of ultrasonographic markers for trisomy 21 in women with positive serum biochemistry. Br J Obstet Gynaecol 105: 63-67.
20. Vergani P, Locatelli A, Piccoli MG, et al. 1999. Best second trimester sonographic markers for the detection of trisomy 21. J Ultrasound Med 18: 469-473.
21. Vintzileos AM, Egan JFX. 1995. Adjusting the risk for trisomy 21 on the basis of second trimester ultrasonography. Am J Obstet Gynecol 172: 837-843.
22. Vintzileos AM, Campbell WA, Rodis JF, Guzman ER, Smulian JC, Knuppel RA. 1996. The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21. Obstet Gynecol 87: 948-952.
23. Vintzileos AM, Campbell WA, Guzman ER, Smulian JC, Mclean DA, Ananth CV. 1997. Second-trimester ultrasound markers for detection of trisomy 21: Which markers are best? Obstet Gynecol 89: 941-944.
24. Whitlow BJ, Lazanakis ML, Kadir RA, Chatzipapas I, Economides DL. 1998. The significance of choroid plexus cysts, echogenic heart foci and renal pyelectasis in the first trimester. Ultrasound Obstet Gynecol 12: 385-390.
25. Wickstorm E, Maizels M, Sabbagha RE, Tamura RK, Cohen LC, Pergament E. 1996a. Isolated fetal pyelectasis: Assessment of risk for postnatal uropathy and Down syndrome. Ultrasound Obstet Gynecol 8: 236-240.
26. Wickstrom EA, Thangavelu M, Parilla BV, Tamura RK, Sabbagha RE. 1996b. A prospective study of the association between isolated fetal pyelectasis and chromosomal abnormality. Obstet Gynecol 88: 379-382.
27. Why Mothers Die. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1994-1996. Department of Health Welsh Office, Scottish Office Department of Health, Department of Health and Social Services, Northern Ireland: London, The Stationary Office, 1998; 257.